MISSISSAUGA, ON, Sept. 4, 2019 /PRNewswire/ - Nuvo Pharmaceuticals
Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian
focused, healthcare company with global reach and a diversified
portfolio of commercial products, today announced that Jesse Ledger, Nuvo's President & Chief
Executive Officer will present at the H.C. Wainwright 21st Annual
Global Investment Conference to be held September 8-10, 2019 in New York City.
Nuvo Presentation Details
Date:
|
Tuesday, September
10, 2019
|
Time:
|
5:00 p.m.
|
Location:
|
Lotte New York Palace
Hotel
|
A link to the live audio webcast of the presentation will be
available on the Home Page of the Company's website
at www.nuvopharmaceuticals.com. The archived webcast
will be available for 30 days.
Mr. Ledger will be available during the conference for
one-on-one meetings. Members of the investment community who
are interested in meeting with the Company should contact
conference coordinators to arrange an appointment or contact Nuvo
directly via email at ir@nuvopharm.com.
About Nuvo Pharmaceuticals Inc.
Nuvo (TSX: NRI; OTCQX: NRIFF) is a Canadian focused, healthcare
company with global reach and a diversified portfolio of commercial
products. The Company targets several therapeutic areas,
including pain, allergy and dermatology. The Company's
strategy is to in-license and acquire growth-oriented,
complementary products for Canadian and international markets and
to out-license select products in global markets. Nuvo's head
office is located in Mississauga,
Ontario, Canada, the international operations are located in
Dublin, Ireland and its
manufacturing facility is located in Varennes, Québec, Canada. The
Varennes facility operates in a
Good Manufacturing Practices (GMP) environment respecting the U.S,
Canada and E.U. GMP regulations
and is regularly inspected by Health Canada and the U.S. Food and
Drug Administration. For additional information, please visit
www.nuvopharmaceuticals.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvo-pharmaceuticals-to-present-at-hc-wainwright-global-investment-conference-300911283.html
SOURCE Nuvo Pharmaceuticals Inc.